Amal Zerrad-Saadi

695 total citations
13 papers, 539 citations indexed

About

Amal Zerrad-Saadi is a scholar working on Obstetrics and Gynecology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amal Zerrad-Saadi has authored 13 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Obstetrics and Gynecology, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amal Zerrad-Saadi's work include Pregnancy and preeclampsia studies (4 papers), Air Quality and Health Impacts (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Amal Zerrad-Saadi is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Air Quality and Health Impacts (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Amal Zerrad-Saadi collaborates with scholars based in France, United States and Belgium. Amal Zerrad-Saadi's co-authors include Patrice Thérond, M. John Chapman, Martine Couturier, Sandrine Chantepie, Anatol Kontush, Anne Nègre‐Salvayre, Juliana Aparecida Souza, Kerry‐Anne Rye, Thierry Fournier and Hélène Gilgenkrantz and has published in prestigious journals such as Journal of Hazardous Materials, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Amal Zerrad-Saadi

12 papers receiving 532 citations

Peers

Countries citing papers authored by Amal Zerrad-Saadi

Since Specialization

Citations

This map shows the geographic impact of Amal Zerrad-Saadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Zerrad-Saadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Zerrad-Saadi more than expected).

Fields of papers citing papers by Amal Zerrad-Saadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal Zerrad-Saadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Zerrad-Saadi. The network helps show where Amal Zerrad-Saadi may publish in the future.

Co-authorship network of co-authors of Amal Zerrad-Saadi

This figure shows the co-authorship network connecting the top 25 collaborators of Amal Zerrad-Saadi. A scholar is included among the top collaborators of Amal Zerrad-Saadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Zerrad-Saadi. Amal Zerrad-Saadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Exposure of the human placental primary cells to nanoplastics induces cytotoxic effects, an inflammatory response and endocrine disruption 2025 ·Journal of Hazardous Materials ·(unknown), (unknown), Abdelhamid Benazzouz, (unknown), J F Colombel, (unknown), Ioana Ferecatu, Thierry Fournier, Jean‐Louis Beaudeux, (unknown), Amal Zerrad-Saadi	5
2	Benzo(a)pyrene and Cerium Dioxide Nanoparticles in Co-Exposure Impair Human Trophoblast Cell Stress Signaling 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Séverine A. Degrelle, (unknown), Marie-Léone Vignaud, (unknown), (unknown), Christelle Laguillier, Xavier Coumoul, Sonja Boland, Thierry Fournier, Amal Zerrad-Saadi, Ioana Ferecatu	3
3	16 Biological Effects of Benzo-[A]-Pyrene and Cerium Nanoparticles on the Human Placental Barrier 2023 ·Annals of Work Exposures and Health ·(unknown), Séverine A. Degrelle, Sonja Boland, Stéphanie Devineau, Marie-Léone Vignaud, (unknown), (unknown), (unknown), Didier Borderie, Thierry Fournier, Amal Zerrad-Saadi, Ioana Ferecatu	0
4	Placental cartography of NADPH oxidase (NOX) family proteins: Involvement in the pathophysiology of preeclampsia 2023 ·Archives of Biochemistry and Biophysics ·(unknown), (unknown), (unknown), (unknown), Marie-Léone Vignaud, Ioana Ferecatu, Thierry Fournier, Jean‐Louis Beaudeux, Amal Zerrad-Saadi	5
5	Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways 2021 ·Antioxidants ·(unknown), (unknown), Jean Guibourdenche, (unknown), Xavier Coumoul, Thierry Fournier, Jean‐Louis Beaudeux, Amal Zerrad-Saadi	11
6	Uptake of Cerium Dioxide Nanoparticles and Impact on Viability, Differentiation and Functions of Primary Trophoblast Cells from Human Placenta 2020 ·Nanomaterials ·(unknown), Sonja Boland, Stéphanie Devineau, Amal Zerrad-Saadi, (unknown), René Lai–Kuen, (unknown), Jean Guibourdenche, (unknown), (unknown), Sophie Gil, Xavier Coumoul, Thierry Fournier, Ioana Ferecatu	18
7	NADPH oxidase is the major source of placental superoxide in early pregnancy: association with MAPK pathway activation 2019 ·Scientific Reports ·(unknown), Thierry Fournier, (unknown), Patrice Thérond, (unknown), Jean‐Louis Beaudeux, Amal Zerrad-Saadi	28
8	Analysis of aquaporin expression in liver with a focus on hepatocytes 2015 ·Histochemistry and Cell Biology ·Françoise Grégoire, Valério Lucidi, Amal Zerrad-Saadi, Myrna Virreira, (unknown), (unknown), Arnaud Lemmers, Vincent Donckier, Jacques Devière, Pieter Demetter, Jason Perret, Christine Delporte	39
9	GH Administration Rescues Fatty Liver Regeneration Impairment by Restoring GH/EGFR Pathway Deficiency 2014 ·Endocrinology ·Alexandra Collin de l’Hortet, Amal Zerrad-Saadi, Carina Prip‐Buus, Véronique Fauveau, (unknown), Marianne Ziol, (unknown), Katy Billot, Véronique Baud, Hélène Gilgenkrantz, Jacques‐Emmanuel Guidotti	35
10	GH Receptor Plays a Major Role in Liver Regeneration through the Control of EGFR and ERK1/2 Activation 2011 ·Endocrinology ·Amal Zerrad-Saadi, (unknown), Claudia Mitchell, (unknown), Alexandra Collin de l’Hortet, Véronique Baud, Fanny Chéreau, Athanassia Sotiropoulos, John J. Kopchick, Lan Liao, Jianming Xu, Hélène Gilgenkrantz, Jacques‐Emmanuel Guidotti	45
11	HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity 2009 ·Arteriosclerosis Thrombosis and Vascular Biology ·Amal Zerrad-Saadi, Patrice Thérond, Sandrine Chantepie, Martine Couturier, Kerry‐Anne Rye, M. John Chapman, Anatol Kontush	130
12	A novel mutation in the human complex I NDUFS7 subunit associated with Leigh syndrome 2007 ·Molecular Genetics and Metabolism ·Sophie Lebon, Diana Rodriguez, Delphine Bridoux, Amal Zerrad-Saadi, Agnès Rötig, Arnold Münnich, Alain Legrand, Abdelhamid Slama	38
13	Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles 2007 ·Arteriosclerosis Thrombosis and Vascular Biology ·Anatol Kontush, Patrice Thérond, Amal Zerrad-Saadi, Martine Couturier, Anne Nègre‐Salvayre, Juliana Aparecida Souza, Sandrine Chantepie, M. John Chapman	182

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact